4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 1,005.00
+20.00 (2.03%)
Jul 8, 2025, 2:00 PM GMT+1
4basebio Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 0.93 | 0.51 | 0.27 | 0.34 | 0.46 | Upgrade
| |
Revenue Growth (YoY) | 84.39% | 88.81% | -20.71% | -26.84% | -42.82% | Upgrade
|
Cost of Revenue | 0.3 | 0.17 | 0.03 | 0.07 | 0.19 | Upgrade
|
Gross Profit | 0.63 | 0.34 | 0.24 | 0.27 | 0.27 | Upgrade
|
Selling, General & Admin | 13.87 | 8.81 | 3.88 | 1.86 | 0.66 | Upgrade
|
Research & Development | - | - | 2.08 | 1.62 | 0.34 | Upgrade
|
Other Operating Expenses | -0.44 | -0.31 | -0.06 | 0.32 | -0.1 | Upgrade
|
Operating Expenses | 13.42 | 8.51 | 5.91 | 3.8 | 0.9 | Upgrade
|
Operating Income | -12.79 | -8.17 | -5.67 | -3.53 | -0.62 | Upgrade
|
Interest Expense | -0.75 | -0.3 | -0.09 | -0.11 | -0.09 | Upgrade
|
Interest & Investment Income | 0.14 | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | 0.75 | 0.11 | -0.17 | - | - | Upgrade
|
EBT Excluding Unusual Items | -12.65 | -8.35 | -5.93 | -3.64 | -0.72 | Upgrade
|
Pretax Income | -12.65 | -8.35 | -5.93 | -3.64 | -0.72 | Upgrade
|
Income Tax Expense | -0.32 | -0.69 | -0.78 | -0.41 | 0 | Upgrade
|
Net Income | -12.33 | -7.67 | -5.15 | -3.24 | -0.72 | Upgrade
|
Net Income to Common | -12.33 | -7.67 | -5.15 | -3.24 | -0.72 | Upgrade
|
Shares Outstanding (Basic) | 13 | 12 | 12 | 12 | 9 | Upgrade
|
Shares Outstanding (Diluted) | 13 | 12 | 12 | 12 | 9 | Upgrade
|
Shares Change (YoY) | 6.47% | 0.01% | - | 37.05% | 4.24% | Upgrade
|
EPS (Basic) | -0.94 | -0.62 | -0.42 | -0.26 | -0.08 | Upgrade
|
EPS (Diluted) | -0.94 | -0.62 | -0.42 | -0.26 | -0.08 | Upgrade
|
Free Cash Flow | -11.44 | -7.05 | -5.86 | -3.62 | -1.37 | Upgrade
|
Free Cash Flow Per Share | -0.87 | -0.57 | -0.48 | -0.29 | -0.15 | Upgrade
|
Gross Margin | 67.52% | 67.19% | 89.18% | 79.59% | 59.31% | Upgrade
|
Operating Margin | -1371.17% | -1613.83% | -2115.30% | -1043.49% | -134.63% | Upgrade
|
Profit Margin | -1321.87% | -1514.82% | -1921.64% | -957.10% | -155.63% | Upgrade
|
Free Cash Flow Margin | -1226.26% | -1393.08% | -2186.19% | -1072.19% | -297.19% | Upgrade
|
EBITDA | -12.04 | -7.6 | -5.33 | -3.35 | -0.58 | Upgrade
|
EBITDA Margin | - | - | - | - | -125.54% | Upgrade
|
D&A For EBITDA | 0.76 | 0.57 | 0.34 | 0.18 | 0.04 | Upgrade
|
EBIT | -12.79 | -8.17 | -5.67 | -3.53 | -0.62 | Upgrade
|
EBIT Margin | - | - | - | - | -134.63% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.